Tag: pharmaceutical updates
Ipsen Completes Kartos Therapeutics Acquisition to Boost Late-Stage Oncology Pipeline
Ipsen has officially completed its acquisition of KartosTherapeutics, a clinical-stage biopharmaceutical company. The transaction integrates navtemadlin, an investigational, first-in-class oral MDM2 inhibitor in Phase 3 clinical development,...
Union Minister Anupriya Patel announced India Must Move from ‘Pharmacy of the World’ to ‘Laboratory of the World
Addressing the third edition of the IIMA Healthcare Summit 2026 on the theme “Advancing AI in Healthcare,” Union Minister of State for Health &...
Sekhmet Pharmaventures Inaugurates Expanded Manufacturing Block at Unit 6 in Chennai
Sekhmet Pharmaventures has officially inaugurated its newly expanded manufacturing block at Unit 6, Chennai (Anjan Drug Private Limited). The expansion represents a key milestone in strengthening the...
First Autonomous Blood-Draw Robot Gets FDA Authorization
The U.S. Food and Drug Administration has given the green light to Aletta, a groundbreaking robotic system capable of performing blood draws entirely on its own...
Union Health Ministry Proposes Inclusion of Four Drugs Under Schedule H1 to Tighten Regulatory Oversight
The Ministry of Health and Family Welfare (MoHFW), Department of Health and Family Welfare, has issued a draft gazette notification (G.S.R. 745(E)) proposing the...
Amylyx Pharmaceuticals Announces Positive Phase 3 Trial Results for Avexitide, for Post-Bariatric Hypoglycemia
Amylyx Pharmaceuticals has announced positive top-line results from its pivotal Phase 3 LUCIDITY trial evaluating avexitide, a first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist being...
